摘要
目的评价右美托咪定对亲体肝移植患儿术后脑损伤的影响。方法择期拟行亲体肝移植术患儿40例,ASA分级Ⅲ或Ⅳ级,年龄5~12月,性别不限,体重5~10 kg,采用随机数字表法分为2组(n=20):右美托咪定组(D组)和对照组(C组)。D组麻醉诱导后静脉给予右美托咪定负荷剂量1 μg/kg,持续泵注10 min,随后以0.3 μg·kg-1·h-1持续泵注;C组给予等容量生理盐水。分别于切皮即刻(T1)、无肝期30 min(T2)、新肝期1 h(T3)、关腹即刻(T4)和术后24 h(T5)时采集中心静脉血样,采用ELISA法检测血清神经元烯醇化酶(NSE)和S-100β蛋白的浓度,术后1 d时采用儿童麻醉苏醒期谵妄评分量表(PAED)评价术后谵妄的发生情况,于术前1 d和术后1周采用贝利婴幼儿发展量表记录患儿智力发展指数(MDI)和运动发展指数(PDI)。结果与T1时比较,2组患儿T2~5时血清NSE和S-100β蛋白浓度升高(P〈0.05);与C组比较,D组T2~5时血清NSE和S-100β蛋白浓度降低,PAED评分和谵妄发生率降低(P〈0.05);与术前1 d时比较,2组患儿术后1周时MDI和PDI降低(P〈0.05);D组术后1周时MDI较C组升高(P〈0.05)。结论右美托咪定可减轻亲体肝移植患儿术后脑损伤。
Objective To evaluate the effect of dexmedetomidine on postoperative brain injury in pediatric patients undergoing living-related liver transplantation. Methods Forty American Society of Anesthesiologists physical status Ⅲ or Ⅳ pediatric patients of both sexes, aged 5-12 months, weighing 5-10 kg, were divided into dexmedetomidine group ( group D, n = 20) and control group ( group C, n = 20) using a random number table. After induction of anesthesia, dexmedetomidine was infused in a loading dose of 1 μg/kg for 10 min followed by a continuous infusion of 0.3 μg · kg-1 · h-1 in group D. The equal volume of normal saline was given instead in group C. Immediately before skin incision (T1 ) , at 30 min of anhepatic phase (T2) , at 1 h of neohepatic phase ( T3 ), immediately after peritoneum closure ( T4 ) and at 24 h after operation ( T5 ), the blood samples were collected from the central vein to detect the concentrations of neuron-specific enolase (NSE) and S-10013 protein in serum by enzyme-linked immunosorbent assay. Postoperative delirium was assessed at 1 day after surgery using Pediatric Anesthesia Emergence Delirium scale. At 1 day before surgery and 1 week after surgery, the Mental Development Index (MDI) and Psy-chomotor Development Index were recorded using Bayley Scale of Infant Development Ⅱ Results The concentrations of serum NSE and S-10013 protein were significantly higher at T2-5 than at T1 in the two groups (P〈0.05). Compared with group C, the concentrations of serum NSE and S-10013 protein were significantly decreased at T2-5 , and the Pediatric Anesthesia Emergence Delirium scale score and incidence of delirium were decreased after surgery in group D (P〈0.05). The MDI and Psychomotor Development Index were significantly lower at 1 week after surgery than at 1 day before surgery in the two groups (P〈0.05). The MDI was significantly higher at 1 week after surgery in group D than in group C (P〈0.05). Conclusion Dexmedetomidine can reduce postoperative brain injury in pediatric patients undergoing living-related liver transplantation.
出处
《中华麻醉学杂志》
CAS
CSCD
北大核心
2017年第2期151-154,共4页
Chinese Journal of Anesthesiology
基金
天津市卫生局科技攻关项目(13KG105,12KG101,2011KY-2)
天津市科委基金项目(05YFJMJC14800)
2016年天津医学会麻醉学分会中青年科研培育基金项目(TJMZJJ-2016-01)
关键词
右美托咪啶
肝移植
脑损伤
Dexmedetomidine
Liver transplantation
Brain injuries